Table 3.
Status of HPV-16 sublineages isolated from different anatomical sites of HNSCC patients and immunoreactivity of p16INK4a and NF-κB biomarkers
No. | HPV16* lineage | HPV16 sublineage | Anatomic site | Primary tumor grade | p16INK4a expression** | Cytoplasmic NF-κB expression*** | Nuclear NF-κB expressionC |
---|---|---|---|---|---|---|---|
1 | A | A1 | Oral cavity | Well differentiated | 2+ | High | Low |
2 | A | A1 | Larynx | Moderately differentiated | 3+ | High | Low |
3 | A | A1 | Larynx | Moderately differentiated | 3+ | High | High |
4 | A | A1 | Oral cavity | Well differentiated | 2+ | High | Low |
5 | A | A2 | Oral cavity | Well differentiated | 3+ | High | Low |
6 | A | A2 | Larynx | Well differentiated | 2+ | High | High |
7 | A | A2 | Hypopharynx | Well differentiated | 3+ | Low | Low |
8 | A | A2 | Tonsil | Well differentiated | 3+ | High | Low |
9 | A | A2 | Base of the tongue | Poorly differentiated | 3+ | High | High |
10 | A | A2 | Base of the tongue | Poorly differentiated | 3+ | High | High |
11 | A | A2 | Hypopharynx | Poorly differentiated | 3+ | High | Low |
12 | D | D2 | Oral cavity | Well differentiated | 2+ | High | Low |
13 | D | D2 | Base of the tongue | Well differentiated | 3+ | High | Low |